These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 15647848

  • 1. Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice.
    Bruell D, Bruns CJ, Yezhelyev M, Huhn M, Müller J, Ischenko I, Fischer R, Finnern R, Jauch KW, Barth S.
    Int J Mol Med; 2005 Feb; 15(2):305-13. PubMed ID: 15647848
    [Abstract] [Full Text] [Related]

  • 2. The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.
    Bruell D, Stöcker M, Huhn M, Redding N, Küpper M, Schumacher P, Paetz A, Bruns CJ, Haisma HJ, Fischer R, Finnern R, Barth S.
    Int J Oncol; 2003 Oct; 23(4):1179-86. PubMed ID: 12964002
    [Abstract] [Full Text] [Related]

  • 3. Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities.
    Niesen J, Stein C, Brehm H, Hehmann-Titt G, Fendel R, Melmer G, Fischer R, Barth S.
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2079-95. PubMed ID: 25899161
    [Abstract] [Full Text] [Related]

  • 4. A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activity.
    Di Paolo C, Willuda J, Kubetzko S, Lauffer I, Tschudi D, Waibel R, Plückthun A, Stahel RA, Zangemeister-Wittke U.
    Clin Cancer Res; 2003 Jul; 9(7):2837-48. PubMed ID: 12855664
    [Abstract] [Full Text] [Related]

  • 5. In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA' in a human acute myeloid leukemia xenograft tumor model.
    Tur MK, Huhn M, Jost E, Thepen T, Brümmendorf TH, Barth S.
    Int J Cancer; 2011 Sep 01; 129(5):1277-82. PubMed ID: 21077160
    [Abstract] [Full Text] [Related]

  • 6. Recombinant anti-CD25 immunotoxin RFT5(SCFV)-ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID mice.
    Barth S, Huhn M, Matthey B, Schnell R, Tawadros S, Schinköthe T, Lorenzen J, Diehl V, Engert A.
    Int J Cancer; 2000 Jun 01; 86(5):718-24. PubMed ID: 10797296
    [Abstract] [Full Text] [Related]

  • 7. Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell lines.
    Barth S, Huhn M, Wels W, Diehl V, Engert A.
    Int J Mol Med; 1998 Jan 01; 1(1):249-56. PubMed ID: 9852227
    [Abstract] [Full Text] [Related]

  • 8. Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors.
    Schmidt M, Maurer-Gebhard M, Groner B, Köhler G, Brochmann-Santos G, Wels W.
    Oncogene; 1999 Mar 04; 18(9):1711-21. PubMed ID: 10208432
    [Abstract] [Full Text] [Related]

  • 9. Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A.
    Akbari B, Farajnia S, Zarghami N, Mahdieh N, Rahmati M, Khosroshahi SA, Barzegar A, Rahbarnia L.
    Anticancer Drugs; 2017 Mar 04; 28(3):263-270. PubMed ID: 27861173
    [Abstract] [Full Text] [Related]

  • 10. Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.
    Kessler C, Pardo A, Tur MK, Gattenlöhner S, Fischer R, Kolberg K, Barth S.
    J Cancer Res Clin Oncol; 2017 Oct 04; 143(10):2025-2038. PubMed ID: 28667390
    [Abstract] [Full Text] [Related]

  • 11. Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo.
    Azemar M, Schmidt M, Arlt F, Kennel P, Brandt B, Papadimitriou A, Groner B, Wels W.
    Int J Cancer; 2000 Apr 15; 86(2):269-75. PubMed ID: 10738256
    [Abstract] [Full Text] [Related]

  • 12. In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model.
    Pardo A, Stöcker M, Kampmeier F, Melmer G, Fischer R, Thepen T, Barth S.
    Cancer Immunol Immunother; 2012 Oct 15; 61(10):1617-26. PubMed ID: 22350071
    [Abstract] [Full Text] [Related]

  • 13. Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13-ETA' and the bispecific scFv [13xds16].
    Grieger E, Gresch G, Niesen J, Woitok M, Barth S, Fischer R, Fendel R, Stein C.
    J Cancer Res Clin Oncol; 2017 Nov 15; 143(11):2159-2170. PubMed ID: 28669053
    [Abstract] [Full Text] [Related]

  • 14. The novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cells.
    Staudinger M, Glorius P, Burger R, Kellner C, Klausz K, Günther A, Repp R, Klapper W, Gramatzki M, Peipp M.
    Blood Cancer J; 2014 Jun 13; 4(6):e219. PubMed ID: 24927408
    [Abstract] [Full Text] [Related]

  • 15. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.
    Tur MK, Huhn M, Thepen T, Stöcker M, Krohn R, Vogel S, Jost E, Osieka R, van de Winkel JG, Fischer R, Finnern R, Barth S.
    Cancer Res; 2003 Dec 01; 63(23):8414-9. PubMed ID: 14679004
    [Abstract] [Full Text] [Related]

  • 16. The novel multispecies Fc-specific Pseudomonas exotoxin A fusion protein α-Fc-ETA' enables screening of antibodies for immunotoxin development.
    Klausz K, Kellner C, Derer S, Valerius T, Staudinger M, Burger R, Gramatzki M, Peipp M.
    J Immunol Methods; 2015 Mar 01; 418():75-83. PubMed ID: 25701195
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin.
    Reiter Y, Kreitman RJ, Brinkmann U, Pastan I.
    Int J Cancer; 1994 Jul 01; 58(1):142-9. PubMed ID: 8014011
    [Abstract] [Full Text] [Related]

  • 18. EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins.
    Wels W, Beerli R, Hellmann P, Schmidt M, Marte BM, Kornilova ES, Hekele A, Mendelsohn J, Groner B, Hynes NE.
    Int J Cancer; 1995 Jan 03; 60(1):137-44. PubMed ID: 7814146
    [Abstract] [Full Text] [Related]

  • 19. A new recombinant immunotoxin hscFv-ETA' demonstrates specific cytotoxicity against chronic myeloid leukemia cells in vitro.
    Zhu X, Tao K, Li Y, Li S, Zhang L, Wang D, Zhong L, Feng W.
    Immunol Lett; 2013 Jan 03; 154(1-2):18-24. PubMed ID: 23954809
    [Abstract] [Full Text] [Related]

  • 20. Human kappa light chain targeted Pseudomonas exotoxin A--identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate development.
    Kellner C, Bleeker WK, Lammerts van Bueren JJ, Staudinger M, Klausz K, Derer S, Glorius P, Muskulus A, de Goeij BE, van de Winkel JG, Parren PW, Valerius T, Gramatzki M, Peipp M.
    J Immunol Methods; 2011 Aug 31; 371(1-2):122-33. PubMed ID: 21756911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.